Your First 100 for Medical Practices & Entrepreneurs
You understand the science. But do you understand the stock? As a healthcare professional, you already have an edge most investors can never buy — you can read clinical literature, evaluate treatment efficacy, and spot genuine medical breakthroughs. The missing piece? The financial framework to turn that expertise into smarter investing decisions. In this episode, I sit down with Bryant Burciaga — former buy-side equity research analyst turned consultant — to help healthcare providers bridge the gap between scientific fluency and financial literacy. We cover: * How to build and interpret financial models for biotech and healthcare equities * The key catalysts that drive stock movement in this sector * Red flags that signal a biotech company is in financial distress * Where to find analyst reports — and how to understand what's already priced into the market For anyone that wanted to translate their scientific knowledge into healthcare/biotech investing, this is a can't miss episode! Your knowledge of medicine is your moat. This episode helps you use it!
22 Folgen
Kommentare
0Sei die erste Person, die kommentiert
Melde dich jetzt an und werde Teil der Your First 100 for Medical Practices & Entrepreneurs-Community!